These studies, excerpted and edited by Barron’s, have been issued lately by funding and analysis companies. The studies are a sampling of analysts’ pondering; they shouldn’t be thought of the views or suggestions of Barron’s. A few of the studies’ issuers have supplied, or hope to offer, investment-banking or different providers to the businesses being analyzed.
New York Group Bancorp
NYCB-NYSE
Outperform • Worth $6.54 on March 17
by Wedbush
We’re upgrading NYCB from Impartial, owing to materials earnings-per-share accretion of 20% from the Signature Financial institution deal. [On March 19], the FDIC introduced that it had entered into a purchase order settlement with Flagstar Financial institution, a subsidiary of NYCB, for a portion of Signature’s mortgage and deposit portfolio.
